News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|April 13, 2020

Improving Treatment Strategies for Wet Age-Related Macular Degeneration

https://www.pharmacytimes.org/on-demand/improving-treatment-strategies-for-wet-agerelated-macular-degeneration

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

CMS. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute

ByGiuliana Grossi

September 9th 2026

Yet Khor, MD, PhD | Image credit: Monash University

Significant Emphysema Linked to Worse ILD Outcomes: Yet Khor, MD, PhD

BySabrina McCrear,Yet Khor, MD, PhD

September 9th 2026

Doctor holding animated liver | Image Credit: Aliaksandr Marko - stock.adobe.com

MASH Comorbidities May Drive Worse Transplant Outcomes

ByBrooke McCormick

September 9th 2026

Lungs | Image credit: Ahmad - AdobeStock

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

ByLaura Joszt, MA

September 8th 2026

FDA approval. | Image credit: @Сергей Шиманович-stock.adobe.com.jpeg

FDA Approves First Disease-Modifying Treatment for AxD

BySabrina McCrear

September 8th 2026

Trending on AJMC

The True Cost of Running a Community CAR T-Cell Program

Bringing CAR T-Cell Therapy Into Community Cancer Centers

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI

FDA Approves First Disease-Modifying Treatment for AxD